Plastikon Healthcare, based in Kansas, is voluntarily recalling a select number of products sold nationally due to possible bacteria contamination.
reported that the pharmaceutical company is recalling three lots of Milk of Magnesia oral suspension, one lot of Acetaminophen and six lots of Magnesium Hydroxide due to microbial contamination and failure to properly investigate failed microbial testing.potentially could result in illness due to intestinal distress, such as diarrhea or abdominal pain, according to the recall.
Currently, Plastikon reports it has not received any customer complaints related to microbial concerns or reports of adverse events related to this recall and said it places the utmost emphasis on patient safety and product quality. The health care company said it has notified its direct customers through a recall letter to arrange for the return of any recalled products. Anyone with an existing inventory of the products being recalled should stop use and distribution, and quarantine immediately.
Plastikon advised returning all quarantined products to the place of purchase. And patients are advised to contact their doctor or health care provider if they have experienced any problems that may be related to the products. Consumers with questions regarding this recall can contact Plastikon by phone at 785-330-7109 or via email at
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA details problems at Abbott plant behind recalled baby formulaThe Food and Drug Administration posted its initial inspection findings from the Abbott plant that’s been tied to several infant hospitalizations, including two deaths, due to a rare bacterial infection.
Les mer »
FDA Authorizes More E-Cigarette ProductsThe U.S. Food and Drug Administration authorized several tobacco-flavored vaping products made by the company Logic, and added that it would soon announce whether other big-name brands can continue to sell their products in this country.
Les mer »
FDA Reviews ALS Drug with Modest DataThe FDA meets next week to publicly review evidence from a small, mid-stage study of AMX0035, a drug made by Amylyx Pharmaceuticals, which shows modest effects on patients’ decline.
Les mer »
FDA expected to authorize second coronavirus booster for 50 and olderThe FDA is poised to authorize a second coronavirus vaccine booster for anyone 50 and older. It would provide an extra layer of protection amid concerns Europe’s rise in infections from an omicron subvariant could hit the United States.
Les mer »
FDA expected to authorize a second Covid booster shot next weekFDA expected to authorize a second Covid booster shot next week. The New York Times, which first reported the news, said late Friday that the Biden administration planned to offer second boosters to Americans age 50 and older.
Les mer »